Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 5:32 pm Sale |
2024-12-31 | 13G | Candel Therapeutics, Inc. CADL |
Northpond Ventures, LP | 0 0.000% |
-1,935,215 (Position Closed) |
Filing History |
| 2024-11-06 4:50 pm Purchase |
2024-11-04 | 13D | Telesis Bio, Inc. TBIO |
Northpond Ventures, LP | 1,039,577 45.900% |
5,031 (+0.49%) |
Filing History |
| 2024-07-18 5:42 pm Purchase |
2024-07-16 | 13D | Telesis Bio, Inc. TBIO |
Northpond Ventures, LP | 1,034,546 47.700% |
1,672 (+0.16%) |
Filing History |
| 2024-06-10 8:40 pm Purchase |
2024-06-06 | 13D | Telesis Bio, Inc. TBIO |
Northpond Ventures, LP | 1,032,874 47.600% |
15,826 (+1.56%) |
Filing History |
| 2023-06-23 5:10 pm Sale |
2023-06-22 | 13D | DICE Therapeutics, Inc. DICE |
Northpond Ventures, LP | 800,000 1.700% |
-2,492,871 (-75.71%) |
Filing History |
| 2023-06-15 4:15 pm Sale |
2023-03-21 | 13D | IsoPlexis Corporation ISO |
Northpond Ventures, LP | 0 0.000% |
-8,808,531 (Position Closed) |
Filing History |
| 2023-06-07 5:00 pm Purchase |
2023-06-05 | 13D | Telesis Bio, Inc. TBIO |
Northpond Ventures, LP | 1,017,048 47.900% |
470,152 (+85.97%) |
Filing History |
| 2023-04-18 9:45 pm Unchanged |
2023-04-17 | 13D | Telesis Bio, Inc. TBIO |
Northpond Ventures, LP | 546,896 33.200% |
0 (Unchanged) |
Filing History |
| 2023-03-29 4:02 pm Purchase |
2023-03-21 | 13G | Bruker Cellular Analysis Inc. CELL |
Northpond Ventures, LP | 5,390,820 5.600% |
5,390,820 (New Position) |
Filing |
| 2022-12-21 7:06 pm Unchanged |
2022-12-21 | 13D | IsoPlexis Corporation ISO |
Northpond Ventures, LP | 8,808,531 22.300% |
0 (Unchanged) |
Filing History |
| 2022-12-16 5:22 pm Unchanged |
2022-11-10 | 13D | Vigil Neuroscience, Inc. VIGL |
Northpond Ventures, LP | 4,214,498 11.800% |
0 (Unchanged) |
Filing History |
| 2022-11-10 4:15 pm Unchanged |
2022-11-09 | 13D | DICE Therapeutics, Inc. DICE |
Northpond Ventures, LP | 3,292,871 6.900% |
0 (Unchanged) |
Filing History |
| 2022-02-14 4:40 pm Purchase |
2021-12-31 | 13G | Candel Therapeutics, Inc. CADL |
Northpond Ventures, LP | 1,935,215 6.700% |
1,935,215 (New Position) |
Filing History |
| 2022-01-19 4:25 pm Purchase |
2022-01-11 | 13D | Vigil Neuroscience, Inc. VIGL |
Northpond Ventures, LP | 4,214,498 14.900% |
4,214,498 (New Position) |
Filing History |
| 2021-10-22 4:28 pm Purchase |
2021-10-12 | 13D | IsoPlexis Corporation ISO |
Northpond Ventures, LP | 8,808,531 22.700% |
8,808,531 (New Position) |
Filing History |
| 2021-09-28 06:04 am Purchase |
2021-09-17 | 13D | DICE Therapeutics, Inc. DICE |
Northpond Ventures, LP | 3,292,871 9.100% |
3,292,871 (New Position) |
Filing History |
| 2021-07-01 5:16 pm Purchase |
2021-06-22 | 13D | Telesis Bio, Inc. TBIO |
Northpond Ventures, LP | 546,896 33.700% |
546,896 (New Position) |
Filing History |